Innovestor Ventures exists Synoste, a Finnish startup that has developed high technology implants for minimally invasive bone lengthening treatment. In addition to Innovestor, Synoste had received investment from High-Tech Gruenderfonds (HTGF), Evonik Venture Capital, Lifeline Ventures, AOL Foundation and angels. Globus Medical acquired Synoste in Q2/2020 for $23.5 million. 

Kickstarting the third generation Limb Lengthening system, Synoste’s unique implants lengthen the bone gradually over a period of months, offering improved outcomes and experiences for patients and surgeons alike.   

Synoste was founded by Harri Hallila, Antti Ritvanen and Juha Haaja, with a shared vision and the know-how needed to bring about third generation limb lengthening systems.  

 “It has been a pleasure working and watching such a driven and ambitious team progress and grow throughout the ups and downs that startups face. Synoste has chosen a great partner in Globus Medical to continue their journey enabling them to take their technology to the next global level” commented Innovestor Venture’s Partner Petri Laine.  

Globus Medical is a leading medical device manufacturer based in Pennsylvania, USA that develops, manufactures, and distributes musculoskeletal device solutions.  

For more information  

Petri Laine

Partner, Innovestor Ventures

petri.laine(a)innovestor.fi

+358 400 909 447